Cargando…
Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass
Background: Ivacaftor, the first CFTR modulator drug, leads to significant long-term improvement in lung function and weight gain. The mechanism as well as the long-term impact of ivacaftor on weight, resting energy expenditure (REE) and body composition remains to be explored. Methods: This prospec...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372433/ https://www.ncbi.nlm.nih.gov/pubmed/37521467 http://dx.doi.org/10.3389/fphar.2023.1157459 |